Serum selenium levels in hemodialysis patients are significantly lower than those in healthy controls

Blood Purification

Volumn 32, Issue 1, 2011, Pages 43-47

  Fujishima, Yosuke ^a,b   Ohsawa, Masaki ^a   Itai, Kazuyoshi ^a   Kato, Karen ^c   Tanno, Kozo ^a   Turin, Tanvir Chowdhury ^e   Onoda, Toshiyuki ^a   Endo, Shigeatsu ^a   Okayama, Akira ^d   Fujioka, Tomoaki ^b  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Department of Urology ^*  (Japan)

^c San ai Hospital   (Japan)

^d FUKUJUJI HOSPITAL   (Japan)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

End stage renal disease; Hemodialysis; Risk factors; Selenium

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SELENIUM; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; JAPAN; MALE; MASS SPECTROMETRY; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK FACTORS; SELENIUM; SERUM ALBUMIN; YOUNG ADULT;

EID: 79751535107     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000323538     Document Type: Article

References (20)

1. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276: 1957-1963. (Pubitemid 26427723)
2. Lippman SM, Klein EA, Goodman PJ, et al: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301: 39-51.
3. leys J, Navas-Acien A, Guallar E: Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med 2008; 168: 404-410. (Pubitemid 351347132)
4. Beck MA, Levander OA, Handy J: Selenium deficiency and viral infection. J Nutr 2003; 133: 1463S-1467S. (Pubitemid 36548727)
5. Nelson HK, Shi Q, Van Dael P, Schiffrin EJ, Blum S, Barclay D, Levander OA, Beck MA: Host nutritional selenium status as a driving force for influenza virus mutations. FASEB J 2001; 15: 1846-1848.
6. Kupka R, Msamanga GI, Spiegelman D, Morris S, Mugusi F, Hunter DJ, Fawzi WW: Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania. J Nutr 2004; 134: 2556-2560. (Pubitemid 39328210)
7. Hoffmann PR, Berry MJ: The influence of selenium on immune responses. Mol Nutr Food Res 2008; 52: 1273-1280.
8. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E: Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 2006; 84: 762-773. (Pubitemid 44715658)
9. Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska P: Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982;ii:175-179. (Pubitemid 12080517)
10. Saint-Georges MD, Bonnefont DJ, Bourely BA, Jaudon MC, Cereze P, Chaumeil P, Gard C, D'Auzac CL: Correction of selenium deficiency in hemodialyzed patients. Kidney Int Suppl 1989; 27:S274-S277. (Pubitemid 19285119)
11. Kallistratos G, Evangelou A, Seferiadis K, Vezyraki P, Barboutis K: Selenium and haemodialysis: serum selenium levels in healthy persons, non-cancer and cancer patients with chronic renal failure. Nephron 1985; 41: 217-222. (Pubitemid 15246664)
12. Dworkin B, Weseley S, Rosenthal WS, Schwartz EM, Weiss L: Diminished blood selenium levels in renal failure patients on dialysis: correlations with nutritional status. Am J Med Sci 1987; 293: 6-12. (Pubitemid 17040492)
13. Hampel G, Schaller KH, Rosenmuller M, Oefele C: Selenium-deficiency as contributing factor to anemia and thrombocytopenia in dialysis patients. Life Support Syst 1985; 3: 36-40.
14. Foote JW, Hinks LJ, Lloyd B: Reduced plasma and white blood cell selenium levels in haemodialysis patients. Clin Chim Acta 1987; 164: 323-328. (Pubitemid 17084001)
15. Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns B, Thadhani R, Gill J, Alberta Kidney Disease Network: Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med 2009; 7: 25.
16. Ohsawa M, Kato K, Itai K, Onoda T, Konda R, Fujioka T, Nakamura M, Okayama A, KAREN Study Group: Cardiovascular risk factors in hemodialysis patients: results from baseline data of kaleidoscopic approaches to patients with end-stage renal disease study. J Epidemiol 2005; 15: 96-105. (Pubitemid 41403858)
17. Itai K, Onoda T, Nohara M, Ohsawa M, Tanno K, Sato T, Kuribayashi T, Okayama A: Serum ionic fluoride concentrations are related to renal function and menopause status but not to age in a Japanese general population. Clin Chim Acta 2010; 411: 263-266.
18. Kennedy J, Carey R, Coolen R, Garber C, Lee H, Levine J, Osberg I: Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline. Wayne, National Committee for Clinical Laboratory Standards, 1999.
19. Neve J: Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity. J Trace Elem Med Biol 1995; 9: 65-73.
20. Högberg J, Alexander J: Selenium; in Nordberg GF, Nordberg BA, Friberg M (eds): Handbook on the Toxicology of Metals. Amsterdam, Elsevier, 2007, pp 783-807.